Systemic mast cell disease associated with primary ovarian mixed malignant germ cell tumor.

Keywords

Mast cell, Germ cell, Chemotherapy, Ovary, Germ cell tumors

References

• The clonal nature of mediastinal germ cell tumors and acute myelogenous leukemia. A case report and review of the literature.Kelley Woodruff, Nancy Wang, William May — 1995
• A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells.Xianhua Piao, Alan Bernstein — 1996
• Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development.Hisahiro Yoshida, Nobuyuki Takakura, Hiroshi Kataoka — 1997
• Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles.Neal G. Copeland, Debra J. Gilbert, Brian C. Cho — 1990
• Systemic Mast Cell Disease: ANALYSIS OF 58 CASES AND LITERATURE REVIEWWilliam D. Travis, Chin‐Yang Li, Erik J. Bergstralh — 1988
• Association between mediastinal germ cell tumors and hematologic malignancies: Report of two cases and review of the literatureSamuel H. Dement, Joseph C. Eggleston, Jerry L. Spivak — 1985
• Systemic mast cell disease associated with primary mediastinal germ cell tumor.Patrick Chariot, I. Monnet, F. Lelong — 1991
• Systemic mastocytosis following mediastinal germ cell tumor: an association confirmed.Patrick Chariot, I. Monnet, Philippe Gaulard — 1993
• Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.H Nagata, A S Worobec, Chang Kyu Oh — 1995
• Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patientsJ Pedersen-Bjergaard, Preben Philip, Niels Tinggaård Pedersen — 1984
• Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmB. Jack Longley, Lynda Tyrrell, Shu-Zhuang Lu — 1996
• Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivoJohn J. Costa, George D. Demetri, Terence J. Harrist — 1996
• W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor.Alastair D. Reith, Robert Rottapel, Elizabeth B. Giddens — 1990

Cited by

• Mastocitose cutanea e tumor de celulas germinativas: uma rara associacaoTelma Kanagusuko, Roberto Miyasaki, Maria Cristina Valencio — 2003
• Paediatric mastocytosis: a systematic review of 1747 casesC. Méni, Julie Bruneau, Sophie Georgin‐Lavialle — 2015
• Hematologic malignancies associated with germ cell tumorsGuang‐Quan Zhao, Jonathan E. Dowell — 2012
• Cutaneous mastocytosis associated with a mixed germ cell tumour of the ovary: report of a case and review of the literatureShigeru Miyagawa, Seiichi Hirota, Y-D. Park — 2001
• Mastocytosis in ChildhoodRogier Heide, Bhupendra Tank, Arnold P. Oranje — 2002
• Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitorsPaola Pittoni, Silvia Piconese, Claudio Tripodo — 2011
• Transdifferentiation and nuclear reprogramming in hematopoietic development and neoplasiaSamuel W. French, Katrina K. Hoyer, Rhine R. Shen — 2002
• Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states.Jae Wook Lee, Woo Sik Yang, Seung Yun Chung — 2007
• Ovarian fibrosarcoma producing multiple cytokinesTakeaki Fukuda, Tomiko Yamaguchi, Toshifumi Yamaki — 2001
• Aggressive Systemic Mastocytosis Following Ovarian Germ Cell TumorEun Ju Huh, So Young Park, Sang Rhim Choi — 2005
• Treatment of systemic mast cell disorders.Alexandra S. Worobec — 2000
• Mast cell disease and malignant germ cell tumors.Ricardo Drut — 1999
• Progressive Hautveränderung bei einem SäuglingAnja Müller, M Domula, S. Stéphan — 2001
• A variant c‐KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemiaSarah G. Mitchell, Silvia T. Bunting, Debra Saxe — 2017
• An aggressive systemic mastocytosis preceded by ovarian dysgerminomaMakiko Tsutsumi, Hiroki Miura, Hidehito Inagaki — 2020
• Ovarian germ cell tumor/mastocytosis with KIT mutation: A unique clinicopathological entityPeifang Xiao, Ping Chen, Xingping Lang — 2021
• A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset CaseValérie Larouche, Marie‐Frédérique Paré, Pierre‐Olivier Grenier — 2023
• ReplyMichael A. Teitell, Jon M. Rowland — 1999
• Additional file 4 of An aggressive systemic mastocytosis preceded by ovarian dysgerminomaTsutsumi, Makiko, Miura, Hiroki, Inagaki, Hidehito — 2020
• Ovarian germ cell tumorsP. Russell, S. Robboy, J. Prat — 2009

Related papers

• High‐dose salvage chemotherapy. Germ‐cell tumor treatment results in GermanyOliver Rick, W. Siegert, J�rg Beyer — 1999
• Malignant germ-cell tumors of the ovary.David M. Gershenson, J. Taylor Wharton — 1985
• Поздние Осложнения Лечения Больных Герминогенными ОпухолямиD. G. Danielyan, A. A. Salimova, A. Bulanov — 2020
• Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms.Ronald M. Bukowski, Gregory W. Smith, James E. Montie — 1988
• Malignant germ cell tumors of the ovary.Robert J. Kurman, Henry J. Norris — 1977
• [P53 protein expression in malignant germ cell tumor of ovary and its relationship with clinical course and prognosis].Gao G, Zhihai Peng, H Wang — 1997